ATE443138T1 - Hemmung der expression von spag9 mit sirnas - Google Patents

Hemmung der expression von spag9 mit sirnas

Info

Publication number
ATE443138T1
ATE443138T1 AT06710485T AT06710485T ATE443138T1 AT E443138 T1 ATE443138 T1 AT E443138T1 AT 06710485 T AT06710485 T AT 06710485T AT 06710485 T AT06710485 T AT 06710485T AT E443138 T1 ATE443138 T1 AT E443138T1
Authority
AT
Austria
Prior art keywords
spag9
sirnas
inhibition
expression
relates
Prior art date
Application number
AT06710485T
Other languages
English (en)
Inventor
Anil Kumar Suri
Original Assignee
Nat Inst Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Immunology filed Critical Nat Inst Immunology
Application granted granted Critical
Publication of ATE443138T1 publication Critical patent/ATE443138T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06710485T 2005-03-02 2006-03-02 Hemmung der expression von spag9 mit sirnas ATE443138T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN466DE2005 2005-03-02
PCT/IB2006/000445 WO2006092714A2 (en) 2005-03-02 2006-03-02 Inhibition of spag9 expression with sirnas

Publications (1)

Publication Number Publication Date
ATE443138T1 true ATE443138T1 (de) 2009-10-15

Family

ID=36763952

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06710485T ATE443138T1 (de) 2005-03-02 2006-03-02 Hemmung der expression von spag9 mit sirnas

Country Status (7)

Country Link
US (1) US8227591B2 (de)
EP (1) EP1861496B1 (de)
JP (1) JP2008531037A (de)
AT (1) ATE443138T1 (de)
AU (1) AU2006219666B2 (de)
DE (1) DE602006009234D1 (de)
WO (1) WO2006092714A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102590510A (zh) * 2012-02-02 2012-07-18 任碧琼 抗spag9抗体在肿瘤的早期辅助诊断中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086071A2 (en) * 2001-04-20 2002-10-31 Ludwig Institute For Cancer Research Cancer-testis antigens
AU2003207708A1 (en) * 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
AU2003295328A1 (en) * 2002-10-02 2004-04-23 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
DK2284266T3 (da) * 2002-11-14 2014-01-13 Thermo Fisher Scient Biosciences Inc sIRNA-MOLEKYLE MOD TP53
CA2568413A1 (en) * 2004-05-28 2005-12-15 Dana-Farber Cancer Institute, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer

Also Published As

Publication number Publication date
JP2008531037A (ja) 2008-08-14
US20090298740A1 (en) 2009-12-03
DE602006009234D1 (de) 2009-10-29
WO2006092714A2 (en) 2006-09-08
WO2006092714A3 (en) 2007-03-15
AU2006219666B2 (en) 2011-01-27
US8227591B2 (en) 2012-07-24
AU2006219666A1 (en) 2006-09-08
EP1861496B1 (de) 2009-09-16
EP1861496A2 (de) 2007-12-05

Similar Documents

Publication Publication Date Title
CY1121899T1 (el) Βοριουχα μικρομορια ως αντιφλεγμονωδεις παραγοντες
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
EA200700717A1 (ru) Сульфонамиды
EA201171367A1 (ru) Винилиндазолильные соединения
PH12015501953A1 (en) Substituted nucleotide analogs
EA201792185A2 (ru) Модуляция экспрессии трансдуктора сигнала и активатора транскрипции 3 (stat3)
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
AR061230A1 (es) Prolongacion de la supervivencia de pacientes con cancer con niveles elevados de egf o tgf-alfa
EA200970738A1 (ru) Ингибиторы активности akt
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA201190178A1 (ru) Замещённые нуклеозидные и нуклеотидные аналоги
EA201071100A1 (ru) Пиридилсодержащие ингибиторы передачи сигнала через белок hedgehog
ATE539752T1 (de) Verwendung von pi3k- und mek-modulatoren bei der krebsbehandlung
RU2448096C3 (ru) Диарилгидантоины
EA201170521A1 (ru) Новые соединения
EA201291194A1 (ru) Индолы
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
TN2009000521A1 (en) Rnai inhibition of alpha-enac expression
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201890768A3 (ru) Лечение злокачественной опухоли ингибиторами tor-киназы
EA200900571A1 (ru) Композиции chk1 ингибиторов
EA201170831A1 (ru) Аминопиразольное соединение
EA201100874A1 (ru) Соединения для лечения рака
EA201170344A1 (ru) Азаиндольные ингибиторы iap
MX2015012063A (es) Oligonucleotidos antisentido para el tratamiento de celulas madre del cancer.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties